2020 ReviewYear ended March 2021

Scroll to learn more

Meiji's Business

The Meiji Group provides customers of all ages ―from infants to seniors― with a wide range of products for healthy and fulfilling lives. From delicious confectionaries and wholesome dairy products to body-enhancing nutrition supplements and vital pharmaceuticals, we make people's wellness our main mission.

Meiji's Business

Key Figures

Net Sales
¥1,191.7 billion
4.9%
Operating Income Ratio
8.9 %
0.7 percentage points
Capital Expenditures
¥67.9 billion
Operating Income
¥106.0 billion
3.3%
ROE
11.1 %
1.3 percentage points
R&D Expenses
¥31.4 billion

Breakdown by Segment

Breakdown by Segment

Business Performance Analysis

Food

Net Sales
¥999.6 billion
4.8%
Operating Income
¥87.4 billion
0.1%

Income Analysis

Pharmaceuticals

Net Sales
¥193.6 billion
5.2%
Operating Income
¥19.1 billion
19.5%

Income Analysis

Capital Expenditures

Capital Expenditures

Food

¥56.4 billion

Pharmaceuticals

¥11.3 billion

Cash Dividends per Share / Dividend Payout Ratio

Dividend Payout Ratio / Cash Dividends per Share

Future Prospects

This is our Medium - Term Business Plan, FYE March 2022 through FYE March 2024.
Our consolidated earnings forecast is as follows:

FYE 3/2021
Results
Net sales ¥1,191.7 billion
Operating income ¥106.0 billion
Operating income ratio 8.9%
ROE 11.1%

FYE 3/2024
Targets
¥1,080.0 billion
¥120.0 billion
11.1%
11.0%

(as of May 18, 2021)

  • *The Accounting Standard for Revenue Recognition is applied from FYE March 2022. As such, the above targets are calculted based on assumption of accounting treatment changes related to revenue recognition.